Revisión

Trombosis de las venas y senos cerebrales

Se resumen los conceptos modernos sobre la patogenia de la trombosis sinusal, los factores de riesgo y el diagnóstico clínico y radiológico.

Artículos

/ Publicado el 26 de diciembre de 2005

Autor/a: Jan Stam

Fuente: N Eng J Med. 352(17):1791-1798, 28 abril, 2005

Indice
1. Bibliografía
2. Desarrollo

1. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35:664-670. 

2. Majoie CB, van Straten M, Venema HW, den Heeten GJ. Multisection CT venography of the dural sinuses and cerebral veins by using matched mask bone elimination. AJNR Am J Neuroradiol 2004;25:787-791. 

3. Corvol JC, Oppenheim C, Manai R, et al. Diffusion-weighted magnetic resonance imaging in a case of cerebral venous thrombosis. Stroke 1998;29:2649-2652. 

4. Yoshikawa T, Abe O, Tsuchiya K, et al. Diffusion-weighted magnetic resonance imaging of dural sinus thrombosis. Neuroradiology 2002;44:481-488. 

5. Bousser M-G, Ross Russell RW. Cerebral venous thrombosis. London: W.B. Saunders, 1997.

6. deVeber G, Andrew M. Cerebral sinovenous thrombosis in children. N Engl J Med 2001;345:417-423. 

7. Deschiens MA, Conard J, Horellou MH, et al. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996;27:1724-1730. 

8. Enevoldson TP, Russell RW. Cerebral venous thrombosis: new causes for an old syndrome? Q J Med 1990;77:1255-1275. 

9. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998;338:1793-1797. 

10. Ludemann P, Nabavi DG, Junker R, et al. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients. Stroke 1998;29:2507-2510. 

11. Weih M, Junge-Hulsing J, Mehraein S, Ziemer S, Einhaupl KM. Hereditare Thrombophilien bei ischamischem Schlaganfall und Sinusvenenthrombosen: Diagnostik, Therapie und Meta-Analyse. Nervenarzt 2000;71:936-945. 

12. Reuner KH, Ruf A, Grau A, et al. Prothrombin gene G20210. A transition is a risk factor for cerebral venous thrombosis. Stroke 1998;29:1765-1769. 

13. Hillier CE, Collins PW, Bowen DJ, Bowley S, Wiles CM. Inherited prothrombotic risk factors and cerebral venous thrombosis. QJM 1998;91:677-680. 

14. Cantu C, Alonso E, Jara A, et al. Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke 2004;35:1790-1794. 

15. Carhuapoma JR, Mitsias P, Levine SR. Cerebral venous thrombosis and anticardiolipin antibodies. Stroke 1997;28:2363-2369. 

16. Cantu C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium: review of 67 cases. Stroke 1993;24:1880-1884. 

17. Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000;31:1274-1282. 

18. Vidailhet M, Piette JC, Wechsler B, Bousser MG, Brunet P. Cerebral venous thrombosis in systemic lupus erythematosus. Stroke 1990;21:1226-1231. 

19. Daif A, Awada A, al-Rajeh S, et al. Cerebral venous thrombosis in adults: a study of 40 cases from Saudi Arabia. Stroke 1995;26:1193-1195. 

20. Farah S, Al-Shubaili A, Montaser A, et al. Behcet's syndrome: a report of 41 patients with emphasis on neurological manifestations. J Neurol Neurosurg Psychiatry 1998;64:382-384.